BUPIZENGE Trademark
Serial Number: 79164086 • Registration: 4839017
BUPIZENGE is a trademark filed by
MOBERG PHARMA AB
on March 24, 2015. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
VALEA AB
P.O. Box 7086
SE-103 87 Stockholm,
SWEDEN
Trademark Details
Filing Date
March 24, 2015
Registration Date
October 27, 2015
Published for Opposition
August 11, 2015
Cancellation Date
March 25, 2025
Goods & Services
Medicated lozenges for pain relief; medicated lozenges for oral cancer treatment
Filing History
DEATH OF INTERNATIONAL REGISTRATION
Oct 10, 2025 DETH
CHANGE OF OWNER RECEIVED FROM IB
Oct 27, 2023 CHLD
TOTAL INVALIDATION PROCESSED BY THE IB
Mar 28, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 3, 2023 INTS
INVALIDATION PROCESSED
Mar 2, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 13, 2023 INTR
NEW REPRESENTATIVE AT IB RECEIVED
Oct 28, 2022 NREP
CANCELLED SECTION 71
May 13, 2022 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Feb 27, 2020 NREP
NOTIFICATION PROCESSED BY IB
Feb 5, 2016 GPNX
GENERIC MADRID TRANSACTION SENT TO IB
Jan 19, 2016 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 19, 2016 XXCR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 26, 2015 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 27, 2015 R.PR
NOTIFICATION PROCESSED BY IB
Aug 21, 2015 GPNX
PUBLISHED FOR OPPOSITION
Aug 11, 2015 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 5, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 5, 2015 OP2R
NOTICE OF PUBLICATION
Jul 22, 2015 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 29, 2015 CNSA
ASSIGNED TO EXAMINER
Jun 27, 2015 DOCK
APPLICATION FILING RECEIPT MAILED
May 8, 2015 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 4, 2015 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 1, 2015 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 30, 2015 REPR
